Dawaa Reference

chronic

Mastoiditis

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD05.02 - condition scope only, no dose · Mastoiditis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK560877/ · Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)

Verified against1 document
  • Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (6)

  • Young children under two often present with irritability, fussiness, lethargy, fever, ear pulling, and ear pain [ear pain · fever · irritability · lethargy]
  • In adults, severe ear pain with fever and a headache is the typical complaint [ear pain · fever · headache]
  • It is almost always a complication of an acute middle ear infection
  • Children catch middle ear infections more readily, so they are the ones who get this
  • Red flag: left untreated it ends in meningitis, an abscess inside the skull, or a clot in a venous sinus [abscess]
  • Red flag: even now, one in ten children who reach those complications dies of them

Signs — what you find (3)

  • Redness, tenderness, warmth, and fluctuance behind the ear with the auricle pushed forward [redness]
  • Otoscopy shows bulging of the back-upper canal wall and a bulging, pus-filled eardrum, sometimes ruptured and draining [pus]
  • A normal-looking eardrum usually, though not always, rules out acute mastoiditis

Tests (3)

  • CBC typically shows a raised white cell count with a left shift, plus raised ESR and CRP
  • CT can show loss of the bony walls between mastoid air cells
  • CT may show thickened or disrupted periosteum, or a collection beneath it (subperiosteal abscess)

If not this — what else fits (3)

  • Tumors mimicking mastoiditis are more often bilateral, involve cranial nerves, and less often cause fever
  • Cellulitis, otitis externa, lymphadenopathy, trauma, and tumor can all mimic acute mastoiditis
  • Rarely the air cells alone are infected, called incipient mastoiditis, or a grumbling middle ear gives the subacute form

SourceStatPearls "Mastoiditis" - disease-level clinical article

Presentation findings are traced to the source above.

Rx: Antibiotic | Main treatment

ANTIBIOTIC

1

CEFTRIAXONE

Antibiotic

1st line

Strength1000 mg

Forminjection

Adult dose and duration

1-2 g once daily by intravenous or intramuscular injection - Reviewed at 48 hours - failure to improve by then is an indication for mastoidectomy

Paediatric dose

50-75 mg/kg/dose [child max 1000 mg]

(Infants, children and adolescents, mild to moderate infection: 50-75 mg/kg as a single daily dose, maximum 1,000 mg a day. Severe infection: 100 mg/kg/day divided every 12 to 24 hours, maximum 4,000 mg/day.)

Dose by weight
3kg150-225 mg/dose
4kg200-300 mg/dose
5kg250-375 mg/dose
6kg300-450 mg/dose
7kg350-525 mg/dose
8kg400-600 mg/dose
9kg450-675 mg/dose
10kg500-750 mg/dose
11kg550-825 mg/dose
12kg600-900 mg/dose
13kg650-975 mg/dose
14kg700-1000 mg/dose (upper capped)
15kg750-1000 mg/dose (upper capped)
16kg800-1000 mg/dose (upper capped)
17kg850-1000 mg/dose (upper capped)
18kg900-1000 mg/dose (upper capped)
19kg950-1000 mg/dose (upper capped)
20kg1000 mg/dose (capped)
21kg1000 mg/dose (capped)
22kg1000 mg/dose (capped)
23kg1000 mg/dose (capped)
24kg1000 mg/dose (capped)
25kg1000 mg/dose (capped)
26kg1000 mg/dose (capped)
27kg1000 mg/dose (capped)
28kg1000 mg/dose (capped)
29kg1000 mg/dose (capped)
30kg1000 mg/dose (capped)
31kg1000 mg/dose (capped)
32kg1000 mg/dose (capped)
33kg1000 mg/dose (capped)
34kg1000 mg/dose (capped)
35kg1000 mg/dose (capped)
36kg1000 mg/dose (capped)
37kg1000 mg/dose (capped)
38kg1000 mg/dose (capped)
39kg1000 mg/dose (capped)
40kg1000 mg/dose (capped)
41kg1000 mg/dose (capped)
42kg1000 mg/dose (capped)
43kg1000 mg/dose (capped)
44kg1000 mg/dose (capped)
45kg1000 mg/dose (capped)
46kg1000 mg/dose (capped)
47kg1000 mg/dose (capped)
48kg1000 mg/dose (capped)
49kg1000 mg/dose (capped)
50kg1000 mg/dose (capped)
AWaRe

WATCH group - carries resistance cost. Egyptian EML 2025.

Dose source

Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)

Why

The cited article says antibiotics are the centrepiece of treatment, that most patients with acute mastoiditis are admitted, and that the uncomplicated patient with no significant history has been treated successfully as an outpatient on daily intravenous ceftriaxone with a low complication rate. The formulary's ceftriaxone monograph names acute otitis media - the infection mastoiditis grows out of - among its indications and gives the paediatric weight rule below. Antibiotics alone still leave an 8.5% complication rate in the article's figures, which is why this drug goes with a referral and not instead of one.

Cautions
  • SEND THE PATIENT IN. The article says most patients with acute mastoiditis are admitted, and that a myringotomy with a grommet, or a mastoidectomy, may be needed alongside the antibiotic.
  • REVIEW AT 48 HOURS. The article says mastoidectomy is indicated if mastoiditis has not improved by then, and warns that the clinical state can deteriorate quickly - serial examination, not one look.
  • WHAT MAKES IT COMPLICATED, in the article's words: a large lesion behind the ear, bone erosion on imaging, high fever, or any neurological sign. Any of these and outpatient treatment is off the table.
  • The article's own first choice for the inpatient without chronic otitis media is intravenous vancomycin alone, with an anti-pseudomonal drug added where there is a long history of ear infection. Neither the article nor the Egyptian formulary states a vancomycin dose, so no vancomycin row is printed here - that dose has to come from the admitting unit.
  • Do not give to anyone with a known allergy to ceftriaxone or another cephalosporin. Never with an intravenous calcium-containing fluid in a baby of 28 days or under, and not in a jaundiced newborn.
Egyptian brands
Egyptian brandManufacturerIndicative price
ZOXIDEL 1 GM PD. FOR I.M. INJ.RAMEDA > DELTA PHARMA22.00 EGP
CEFTRIAXONE SODIUM 1 GM I.M.VIAL (KAHIRA)KAHIRA29.00 EGP
ZOXIDEL 1 GM PD. FOR I.V. INJ.RAMEDA > DELTA PHARMA29.00 EGP
WINTRIAXONE 1 GM PD. FOR I.V INJ.SANOFI48.00 EGP
VOTRIAXONE 1 GM I.M VIALCHEMIPHARM56.00 EGP
OFRAMAX 1 GM I.M. VIALRAMEDA > SUN PHARMA EGYPT LIMITED71.00 EGP
TRIAXONE 1 GM I.M. VIALTABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA106.00 EGP
TRIAXONE 1 GM I.V VIALTABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA106.00 EGP

MAIN TREATMENT

2

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line
Adult dose and duration

Acute mastoiditis is a potentially life-threatening suppurative complication of acute otitis media that requires immediate same-day hospital admission rather than outpatient oral antibiotic therapy. Key clinical signs include retroauricular erythema, warmth, fluctuant swelling (subperiosteal abscess), tenderness over the mastoid process, and outward/downward displacement of the pinna. Arrange urgent emergency transport for high-dose intravenous broad-spectrum antibiotics, urgent temporal bone CT imaging, and ENT surgical intervention (myringotomy, subperiosteal abscess drainage, or cortical mastoidectomy) to prevent lethal intracranial spread. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Acute mastoiditis is a potentially life-threatening suppurative complication of acute otitis media that requires immediate same-day hospital admission rather than outpatient oral antibiotic therapy. Key clinical signs include retroauricular erythema, warmth, fluctuant swelling (subperiosteal abscess), tenderness over the mastoid process, and outward/downward displacement of the pinna. Arrange urgent emergency transport for high-dose intravenous broad-spectrum antibiotics, urgent temporal bone CT imaging, and ENT surgical intervention (myringotomy, subperiosteal abscess drainage, or cortical mastoidectomy) to prevent lethal intracranial spread.

Cautions
  • The drug rows above are what the treating service gives. They are here so that the referral is an informed one and so the GP can recognise the regimen the patient comes back on - not as permission to start it without the referral.
  • RED FLAG - Swelling or redness behind the ear pushing it forward, high fever with systemic illness, or signs of intracranial spread such as severe headache, neck stiffness, or altered consciousness.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.